{
    "medicine_id": "f69f9d6e02dff2a9ab5e9b213903dd8c87e7e636",
    "platform_id": "DB11331",
    "metadata": {
        "name": "Surfaxin Suspension",
        "composition": "1 Palmitoyl 2 oleoyl sn glycero 3 phospho rac 1 glycerol",
        "clinical_particulars": {
            "therapeutic_indications": "Palmitoyloleoyl phosphatidylglycerol was a component of Surfaxin which was indicated for the prevention of respiratory distress syndrome in premature infants",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Palmitoyloleoyl phosphatidylglycerol is a replacement surfactant which prevents alveolar collapse when administered intratracheally",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}